Cutler Group’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-27
| Closed | -$7K | – | 2335 |
|
|
2022
Q3 | $7K | Buy |
+27
| New | +$7K | ﹤0.01% | 1464 |
|
|
2022
Q1 | – | Sell |
-9
| Closed | -$1K | – | 2548 |
|
|
2021
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 1982 |
|
|
2021
Q3 | $2K | Buy |
9
+2
| +29% | +$444 | ﹤0.01% | 1971 |
|
|
2021
Q2 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 1975 |
|
|
2019
Q1 | – | Sell |
-7
| Closed | -$1K | – | 2157 |
|
|
2018
Q4 | $1K | Sell |
7
-67
| -91% | -$9.57K | ﹤0.01% | 1537 |
|
|
2018
Q3 | $33K | Buy |
74
+37
| +100% | +$16.5K | ﹤0.01% | 1045 |
|
|
2018
Q2 | $16K | Sell |
37
-4
| -10% | -$1.73K | ﹤0.01% | 1188 |
|
|
2018
Q1 | $24K | Buy |
41
+10
| +32% | +$5.85K | ﹤0.01% | 1137 |
|
|
2017
Q4 | $19K | Sell |
31
-12
| -28% | -$7.36K | ﹤0.01% | 1411 |
|
|
2017
Q3 | $39K | Buy |
43
+40
| +1,333% | +$36.3K | ﹤0.01% | 1366 |
|
|
2017
Q2 | $3K | Buy |
+3
| New | +$3K | ﹤0.01% | 2533 |
|
|
2017
Q1 | – | Sell |
-152
| Closed | -$122K | – | 3348 |
|
|
2016
Q4 | $122K | Buy |
152
+100
| +192% | +$80.3K | ﹤0.01% | 1097 |
|
|
2016
Q3 | $44K | Buy |
52
+8
| +18% | +$6.77K | ﹤0.01% | 1483 |
|
|
2016
Q2 | $35K | Sell |
44
-27
| -38% | -$21.5K | ﹤0.01% | 1539 |
|
|
2016
Q1 | $79K | Sell |
71
-394
| -85% | -$438K | 0.01% | 1049 |
|
|
2015
Q4 | $579K | Buy |
+465
| New | +$579K | 0.03% | 347 |
|